FEATURED ARTICLES

• A Comparison Of 6 Analytical Validation Guidelines Using Data Envelopment Analysis

  This is the first published application of data envelopment analysis to six major pharmaceutical analytical validation guidelines, including ICH Q2(R2), USP, ChP, and Brazil's ANVISA.

• Why FAT Should Confirm Alignment, Not Reveal Its Absence
• Why Cloud Migration Is The Key To Business Agility
• Applying Contamination Control By Design: A Practical Guide For CDMOs
• Simulating PUPSIT Or Gas Purges In Bacterial Challenge Tests

WHITE PAPERS & CASE STUDIES

• The Essential Ingredient For GxP Training Innovation

  Advanced learning tools depend entirely on the health of the underlying training matrix. Establish a clean, data-driven framework to reduce compliance risks and recover lost operational hours.

• Smarter By The Second Redefining Pharma Biopharma Manufacturing

  Continuous monitoring is transforming manufacturing. With advanced analytics and sensor technologies, teams can detect issues early and optimize processes in real time for greater efficiency.

• Unlocking Operational Capacity With Digitalized Cleaning Validation

  Digitalizing cleaning validation reduces inefficiencies, strengthens data integrity, and improves audit readiness. See how integrated systems can continuously optimize manufacturing performance.

• What Pharmacies Often Miss In USP <800> Compliance

  Master USP <800> compliance by transitioning from standalone equipment to an integrated system design. Review key protocols for a multi-layered strategy to mitigate cumulative drug risks.

• Standardization Of Analytical Data: Best Practices

  Standardized analytical data is key to improving data quality, reuse, and AI readiness. Explore the challenges of fragmented formats and gain practical guidance on building future-proof foundations.

• Accelerating ADC Analytical Method Development Through Platform Innovation

  Leverage a platform-based analytical development strategy to accelerate ADC IND readiness through early CQA identification, reduced development risk, and streamlined progression from development to patients.